[Nineteen new drugs have been newly listed on the pharmaceutical reimbursement list or expanded reimbursement standards from January to this month this year. Among the drugs, 4 items were newly listed drugs, and 2 were already-listed drugs receiving reimbursement expansions.

An estimated 1,320,371 patients will benefit from the new drug coverage enhancement policy this year, and the amount of pharmaceutical expense is expected to be in the ￦437.76 billion range.

First, 19 new drugs have been newly listed on the pharmaceutical reimbursement list or expanded reimbursement standards (indication, administration standards) from January to this month this year.

By mont